var data={"name":"Breast cancer","type":"SECTION","numTopics":"11,000","numSpecialties":"over 22","sections":[{"name":"Carcinoma in situ","type":"SUBSECTION","items":[{"name":"Atypia and lobular carcinoma in situ: High-risk lesions of the breast","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=atypia-and-lobular-carcinoma-in-situ-high-risk-lesions-of-the-breast"},{"name":"Breast ductal carcinoma in situ: Epidemiology, clinical manifestations, and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=breast-ductal-carcinoma-in-situ-epidemiology-clinical-manifestations-and-diagnosis"},{"name":"Ductal carcinoma in situ: Treatment and prognosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=ductal-carcinoma-in-situ-treatment-and-prognosis"},{"name":"Microinvasive breast carcinoma","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=microinvasive-breast-carcinoma"}]},{"name":"Evaluation and screening","type":"SUBSECTION","items":[{"name":"Breast biopsy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=breast-biopsy"},{"name":"Breast imaging for cancer screening: Mammography and ultrasonography","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=breast-imaging-for-cancer-screening-mammography-and-ultrasonography"},{"name":"Clinical features, diagnosis, and staging of newly diagnosed breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-features-diagnosis-and-staging-of-newly-diagnosed-breast-cancer"},{"name":"Diagnostic evaluation of women with suspected breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=diagnostic-evaluation-of-women-with-suspected-breast-cancer"},{"name":"Genetic counseling and testing for hereditary breast and ovarian cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=genetic-counseling-and-testing-for-hereditary-breast-and-ovarian-cancer"},{"name":"Management of patients at high risk for breast and ovarian cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-patients-at-high-risk-for-breast-and-ovarian-cancer"},{"name":"Overview of hereditary breast and ovarian cancer syndromes","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-hereditary-breast-and-ovarian-cancer-syndromes"},{"name":"Screening for breast cancer: Evidence for effectiveness and harms","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=screening-for-breast-cancer-evidence-for-effectiveness-and-harms"},{"name":"Screening for breast cancer: Strategies and recommendations","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=screening-for-breast-cancer-strategies-and-recommendations"},{"name":"Tumor, Node, Metastasis (TNM) staging classification for breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=tumor-node-metastasis-tnm-staging-classification-for-breast-cancer"}]},{"name":"General issues","type":"SUBSECTION","items":[{"name":"Breast development and morphology","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=breast-development-and-morphology"},{"name":"Cardiotoxicity of radiation therapy for breast cancer and other malignancies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cardiotoxicity-of-radiation-therapy-for-breast-cancer-and-other-malignancies"},{"name":"Cardiotoxicity of trastuzumab and other HER2-targeted agents","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cardiotoxicity-of-trastuzumab-and-other-her2-targeted-agents"},{"name":"Factors that modify breast cancer risk in women","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=factors-that-modify-breast-cancer-risk-in-women"},{"name":"Gestational breast cancer: Epidemiology and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=gestational-breast-cancer-epidemiology-and-diagnosis"},{"name":"Gestational breast cancer: Treatment","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=gestational-breast-cancer-treatment"},{"name":"Hormone receptors in breast cancer: Clinical utility and guideline recommendations to improve test accuracy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hormone-receptors-in-breast-cancer-clinical-utility-and-guideline-recommendations-to-improve-test-accuracy"},{"name":"Inflammatory breast cancer: Pathology and molecular pathogenesis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=inflammatory-breast-cancer-pathology-and-molecular-pathogenesis"},{"name":"Management of brain metastases in breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-brain-metastases-in-breast-cancer"},{"name":"Overview of the treatment of newly diagnosed, non-metastatic breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-treatment-of-newly-diagnosed-non-metastatic-breast-cancer"},{"name":"Patterns of relapse and long-term complications of therapy in breast cancer survivors","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=patterns-of-relapse-and-long-term-complications-of-therapy-in-breast-cancer-survivors"},{"name":"Prognostic and predictive factors in early, nonmetastatic breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prognostic-and-predictive-factors-in-early-nonmetastatic-breast-cancer"},{"name":"Prognostic and predictive factors in metastatic breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prognostic-and-predictive-factors-in-metastatic-breast-cancer"},{"name":"Sentinel lymph node biopsy in breast cancer: Techniques","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=sentinel-lymph-node-biopsy-in-breast-cancer-techniques"}]},{"name":"Hormones and hormonal replacement therapy","type":"SUBSECTION","items":[{"name":"Adjuvant endocrine therapy for non-metastatic, hormone receptor-positive breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=adjuvant-endocrine-therapy-for-non-metastatic-hormone-receptor-positive-breast-cancer"},{"name":"Hormone receptors in breast cancer: Clinical utility and guideline recommendations to improve test accuracy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hormone-receptors-in-breast-cancer-clinical-utility-and-guideline-recommendations-to-improve-test-accuracy"},{"name":"Managing the side effects of tamoxifen","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=managing-the-side-effects-of-tamoxifen"},{"name":"Mechanisms of action of selective estrogen receptor modulators and down-regulators","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=mechanisms-of-action-of-selective-estrogen-receptor-modulators-and-down-regulators"},{"name":"Menopausal hormone therapy and the risk of breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=menopausal-hormone-therapy-and-the-risk-of-breast-cancer"},{"name":"Prevalence of BRCA1 and BRCA2 mutations and associated cancer risks","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prevalence-of-brca1-and-brca2-mutations-and-associated-cancer-risks"},{"name":"Selective estrogen receptor modulators and aromatase inhibitors for breast cancer prevention","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=selective-estrogen-receptor-modulators-and-aromatase-inhibitors-for-breast-cancer-prevention"},{"name":"Treatment approach to metastatic hormone receptor-positive, HER2-negative breast cancer: Endocrine therapy and targeted agents","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-approach-to-metastatic-hormone-receptor-positive-her2-negative-breast-cancer-endocrine-therapy-and-targeted-agents"}]},{"name":"Lymphedema","type":"SUBSECTION","items":[{"name":"Breast cancer-associated lymphedema","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=breast-cancer-associated-lymphedema"},{"name":"Clinical features and diagnosis of peripheral lymphedema","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-features-and-diagnosis-of-peripheral-lymphedema"},{"name":"Clinical staging and conservative management of peripheral lymphedema","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-staging-and-conservative-management-of-peripheral-lymphedema"}]},{"name":"Male breast cancer","type":"SUBSECTION","items":[{"name":"Breast cancer in men","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=breast-cancer-in-men"}]},{"name":"Pathology","type":"SUBSECTION","items":[{"name":"Hormone receptors in breast cancer: Clinical utility and guideline recommendations to improve test accuracy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hormone-receptors-in-breast-cancer-clinical-utility-and-guideline-recommendations-to-improve-test-accuracy"},{"name":"Inflammatory breast cancer: Pathology and molecular pathogenesis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=inflammatory-breast-cancer-pathology-and-molecular-pathogenesis"},{"name":"Pathology of breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathology-of-breast-cancer"},{"name":"Prognostic and predictive factors in early, nonmetastatic breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prognostic-and-predictive-factors-in-early-nonmetastatic-breast-cancer"},{"name":"Prognostic and predictive factors in metastatic breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prognostic-and-predictive-factors-in-metastatic-breast-cancer"},{"name":"Sentinel lymph node biopsy in breast cancer: Techniques","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=sentinel-lymph-node-biopsy-in-breast-cancer-techniques"}]},{"name":"Treatment","type":"SUBSECTION","items":[{"name":"Acute side effects of adjuvant chemotherapy for early-stage breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=acute-side-effects-of-adjuvant-chemotherapy-for-early-stage-breast-cancer"},{"name":"Adjuvant chemotherapy for HER2-negative breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=adjuvant-chemotherapy-for-her2-negative-breast-cancer"},{"name":"Adjuvant endocrine therapy for non-metastatic, hormone receptor-positive breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=adjuvant-endocrine-therapy-for-non-metastatic-hormone-receptor-positive-breast-cancer"},{"name":"Adjuvant radiation therapy for women with newly diagnosed, non-metastatic breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=adjuvant-radiation-therapy-for-women-with-newly-diagnosed-non-metastatic-breast-cancer"},{"name":"Adjuvant systemic therapy for HER2-positive breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=adjuvant-systemic-therapy-for-her2-positive-breast-cancer"},{"name":"Axillary node metastases with occult primary breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=axillary-node-metastases-with-occult-primary-breast-cancer"},{"name":"Breast cancer in men","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=breast-cancer-in-men"},{"name":"Breast lymphoma","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=breast-lymphoma"},{"name":"Breast sarcoma: Epidemiology, risk factors, clinical presentation, diagnosis, and staging","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=breast-sarcoma-epidemiology-risk-factors-clinical-presentation-diagnosis-and-staging"},{"name":"Breast sarcoma: Treatment","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=breast-sarcoma-treatment"},{"name":"Cardiotoxicity of radiation therapy for breast cancer and other malignancies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cardiotoxicity-of-radiation-therapy-for-breast-cancer-and-other-malignancies"},{"name":"Cardiotoxicity of trastuzumab and other HER2-targeted agents","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cardiotoxicity-of-trastuzumab-and-other-her2-targeted-agents"},{"name":"Epidemiology, risk factors and the clinical approach to ER/PR negative, HER2-negative (Triple-negative) breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=epidemiology-risk-factors-and-the-clinical-approach-to-er-pr-negative-her2-negative-triple-negative-breast-cancer"},{"name":"General principles of neoadjuvant therapy for breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=general-principles-of-neoadjuvant-therapy-for-breast-cancer"},{"name":"General principles on the treatment of early-stage and locally advanced breast cancer in older women","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=general-principles-on-the-treatment-of-early-stage-and-locally-advanced-breast-cancer-in-older-women"},{"name":"HER2 and predicting response to therapy in breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=her2-and-predicting-response-to-therapy-in-breast-cancer"},{"name":"Implant-based breast reconstruction and augmentation","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=implant-based-breast-reconstruction-and-augmentation"},{"name":"Inflammatory breast cancer: Clinical features and treatment","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=inflammatory-breast-cancer-clinical-features-and-treatment"},{"name":"Management of brain metastases in breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-brain-metastases-in-breast-cancer"},{"name":"Management of locoregional recurrence of breast cancer after breast conserving therapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-locoregional-recurrence-of-breast-cancer-after-breast-conserving-therapy"},{"name":"Management of locoregional recurrence of breast cancer after mastectomy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-locoregional-recurrence-of-breast-cancer-after-mastectomy"},{"name":"Management of the regional lymph nodes in breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-the-regional-lymph-nodes-in-breast-cancer"},{"name":"Neoadjuvant therapy for newly diagnosed hormone-positive breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=neoadjuvant-therapy-for-newly-diagnosed-hormone-positive-breast-cancer"},{"name":"Neoadjuvant therapy for patients with HER2-positive breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=neoadjuvant-therapy-for-patients-with-her2-positive-breast-cancer"},{"name":"Osteoclast inhibitors for patients with bone metastases from breast, prostate, and other solid tumors","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=osteoclast-inhibitors-for-patients-with-bone-metastases-from-breast-prostate-and-other-solid-tumors"},{"name":"Overview of breast reconstruction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-breast-reconstruction"},{"name":"Overview of the treatment of newly diagnosed, non-metastatic breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-treatment-of-newly-diagnosed-non-metastatic-breast-cancer"},{"name":"Overview of the use of osteoclast inhibitors in early breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-use-of-osteoclast-inhibitors-in-early-breast-cancer"},{"name":"Paget disease of the breast","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=paget-disease-of-the-breast"},{"name":"Phyllodes tumors of the breast","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=phyllodes-tumors-of-the-breast"},{"name":"Radiation therapy techniques for newly diagnosed, non-metastatic breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=radiation-therapy-techniques-for-newly-diagnosed-non-metastatic-breast-cancer"},{"name":"Sentinel lymph node biopsy in breast cancer: Techniques","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=sentinel-lymph-node-biopsy-in-breast-cancer-techniques"},{"name":"Systemic treatment for HER2-positive metastatic breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=systemic-treatment-for-her2-positive-metastatic-breast-cancer"},{"name":"Systemic treatment for metastatic breast cancer: General principles","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=systemic-treatment-for-metastatic-breast-cancer-general-principles"},{"name":"Systemic treatment of metastatic breast cancer in women: Chemotherapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=systemic-treatment-of-metastatic-breast-cancer-in-women-chemotherapy"},{"name":"The role of local therapies in metastatic breast cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=the-role-of-local-therapies-in-metastatic-breast-cancer"},{"name":"The roles of diet, physical activity, and body weight in cancer survivorship","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=the-roles-of-diet-physical-activity-and-body-weight-in-cancer-survivorship"},{"name":"Treatment approach to metastatic hormone receptor-positive, HER2-negative breast cancer: Endocrine therapy and targeted agents","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-approach-to-metastatic-hormone-receptor-positive-her2-negative-breast-cancer-endocrine-therapy-and-targeted-agents"},{"name":"Treatment of metastatic breast cancer in older women","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-metastatic-breast-cancer-in-older-women"}]}]}